Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of half-molar sodium lactate versus 3% saline in septic shock
2022-003846-10Phase 2Active
- Sponsor
- Fakultní nemocnice Plzeň
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in septic shock comparing 0.5M sodium lactate bolus with 3% sodium chloride bolus (2 arms). Primary endpoint: Change in cardiac stroke work. Started Oct 2024; status: active.
02
Drugs
Sodium lactatesodium chloride
03
Conditions
septic shock
Beyond the preview
Go deeper on 2022-003846-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-003846-10.